{"id":"https://openalex.org/W2403015085","doi":"https://doi.org/10.3851/imp3056","title":"Primer ID Ultra-Deep Sequencing Reveals Dynamics of drug Resistance-Associated Variants in Breakthrough Hepatitis C Viruses: Relevance to Treatment Outcome and Resistance Screening","display_name":"Primer ID Ultra-Deep Sequencing Reveals Dynamics of drug Resistance-Associated Variants in Breakthrough Hepatitis C Viruses: Relevance to Treatment Outcome and Resistance Screening","publication_year":2015,"publication_date":"2015-10-01","ids":{"openalex":"https://openalex.org/W2403015085","doi":"https://doi.org/10.3851/imp3056","mag":"2403015085","pmid":"https://pubmed.ncbi.nlm.nih.gov/27219495"},"language":"en","primary_location":{"id":"doi:10.3851/imp3056","doi":"https://doi.org/10.3851/imp3056","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp3056","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3056?download=true","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3056?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017064508","display_name":"Richard Barnard","orcid":"https://orcid.org/0000-0001-8691-9779","observed_orcids":["https://orcid.org/0000-0001-8691-9779"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Barnard","raw_affiliation_strings":["Antiviral Research, Merck and Co., West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Research, Merck and Co., West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066623545","display_name":"Abha Chopra","orcid":"https://orcid.org/0000-0001-5008-9080","observed_orcids":["https://orcid.org/0000-0001-5008-9080"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Abha Chopra","raw_affiliation_strings":["Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","institution_ids":["https://openalex.org/I176790772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102049375","display_name":"Ian James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ian James","raw_affiliation_strings":["Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","institution_ids":["https://openalex.org/I176790772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007316400","display_name":"J. Blinco","orcid":"https://orcid.org/0009-0006-5526-6596","observed_orcids":["https://orcid.org/0009-0006-5526-6596"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John Blinco","raw_affiliation_strings":["Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","institution_ids":["https://openalex.org/I176790772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067048300","display_name":"Mark W Watson","orcid":"https://orcid.org/0000-0002-6438-9225","observed_orcids":["https://orcid.org/0000-0002-6438-9225"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mark W Watson","raw_affiliation_strings":["Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","institution_ids":["https://openalex.org/I176790772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011364534","display_name":"Cassandra B. Jabara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210117513","display_name":"10X Genomics (United States)","ror":"https://ror.org/01sxvbm95","country_code":"US","type":"company","lineage":["https://openalex.org/I4210117513"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cassandra B Jabara","raw_affiliation_strings":["Department of Biology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","Present address: 10X Genomics, Inc., Pleasanton, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]},{"raw_affiliation_string":"Present address: 10X Genomics, Inc., Pleasanton, CA, USA","institution_ids":["https://openalex.org/I4210117513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088571596","display_name":"Daria J. Hazuda","orcid":"https://orcid.org/0000-0002-6894-1056","observed_orcids":["https://orcid.org/0000-0002-6894-1056"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daria Hazuda","raw_affiliation_strings":["Antiviral Research, Merck and Co., West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Research, Merck and Co., West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026233059","display_name":"Stanley M. Lemon","orcid":"https://orcid.org/0000-0003-1450-806X","observed_orcids":["https://orcid.org/0000-0003-1450-806X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanley M Lemon","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070165631","display_name":"Simon Alexander Mallal","orcid":"https://orcid.org/0000-0002-7036-1309","observed_orcids":["https://orcid.org/0000-0002-7036-1309"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Simon Mallal","raw_affiliation_strings":["Department of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, TN, USA","Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, USA","Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","institution_ids":["https://openalex.org/I176790772"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080161419","display_name":"Silvana Gaudieri","orcid":"https://orcid.org/0000-0001-6873-0198","observed_orcids":["https://orcid.org/0000-0001-6873-0198"]},"institutions":[{"id":"https://openalex.org/I176790772","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34","country_code":"AU","type":"education","lineage":["https://openalex.org/I176790772"]},{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["AU","US"],"is_corresponding":true,"raw_author_name":"Silvana Gaudieri","raw_affiliation_strings":["Department of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, TN, USA","Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","School of Anatomy, Physiology and Human Biology, University of Western Australia, Crawley, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Disease, Vanderbilt University, Nashville, TN, USA","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia","institution_ids":["https://openalex.org/I176790772"]},{"raw_affiliation_string":"School of Anatomy, Physiology and Human Biology, University of Western Australia, Crawley, Australia","institution_ids":["https://openalex.org/I177877127"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5080161419"],"corresponding_institution_ids":["https://openalex.org/I176790772","https://openalex.org/I177877127","https://openalex.org/I200719446"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":0.6858,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.71931869,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"21","issue":"7","first_page":"567","last_page":"577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10976","display_name":"Viral gastroenteritis research and epidemiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.9869999885559082},{"id":"https://openalex.org/keywords/direct-acting-antivirals","display_name":"direct-acting antivirals","score":0.859000027179718},{"id":"https://openalex.org/keywords/boceprevir","display_name":"boceprevir","score":0.9580000042915344},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.8140000104904175},{"id":"https://openalex.org/keywords/ultra-deep-sequencing","display_name":"ultra-deep sequencing","score":0.847000002861023},{"id":"https://openalex.org/keywords/quasispecies-dynamics","display_name":"quasispecies dynamics","score":0.8019999861717224},{"id":"https://openalex.org/keywords/compensatory-mutations","display_name":"compensatory mutations","score":0.9779999852180481},{"id":"https://openalex.org/keywords/resistance-screening","display_name":"resistance screening","score":0.7900000214576721},{"id":"https://openalex.org/keywords/pcr-bias","display_name":"PCR bias","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C132917006","wikidata":"https://www.wikidata.org/wiki/Q5250436","display_name":"Deep sequencing","level":4,"score":0.7711496353149414},{"id":"https://openalex.org/C14500911","wikidata":"https://www.wikidata.org/wiki/Q3413375","display_name":"Viral quasispecies","level":4,"score":0.7092960476875305},{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.6937828063964844},{"id":"https://openalex.org/C2777563447","wikidata":"https://www.wikidata.org/wiki/Q7243397","display_name":"Primer (cosmetics)","level":2,"score":0.636532723903656},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5705505609512329},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5634722709655762},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.538615882396698},{"id":"https://openalex.org/C2777159539","wikidata":"https://www.wikidata.org/wiki/Q410551","display_name":"Boceprevir","level":5,"score":0.4931127727031708},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.45182815194129944},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.3847866356372833},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3633852005004883},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30137690901756287},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.2581827640533447},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.19488739967346191},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.17186620831489563},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.16353324055671692},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12189146876335144},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000085242","descriptor_name":"Viral Proteases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D043583","descriptor_name":"Nucleoside-Triphosphatase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053487","descriptor_name":"DEAD-box RNA Helicases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059014","descriptor_name":"High-Throughput Nucleotide Sequencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.3851/imp3056","doi":"https://doi.org/10.3851/imp3056","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp3056","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3056?download=true","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:27219495","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27219495","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"},{"id":"pmh:oai:alma.61MUN_INST:11136400830007891","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Primer-ID-ultra-deep-sequencing-reveals-dynamics/991005544373007891","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"text"},{"id":"pmh:oai:pure.atira.dk:publications/01851d66-af8b-4a02-9b93-718577fdf68a","doi":null,"is_oa":false,"landing_page_url":"https://admin.research-repository.uwa.edu.au/en/publications/01851d66-af8b-4a02-9b93-718577fdf68a","pdf_url":null,"source":{"id":"https://openalex.org/S4306402492","display_name":"UWA Profiles and Research Repository (UWA)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177877127","host_organization_name":"The University of Western Australia","host_organization_lineage":["https://openalex.org/I177877127"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Barnard, R, Chopra, A, James, I, Blinco, J, Watson, M W, Jabara, C B, Hazuda, D, Lemon, S M, Mallal, S & Gaudieri, S 2016, 'Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: Relevance to treatment outcome and resistance screening', Antiviral Therapy, vol. 21, no. 7, pp. 567-577. https://doi.org/10.3851/IMP3056","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:researchrepository.murdoch.edu.au:31886","doi":null,"is_oa":false,"landing_page_url":"https://researchrepository.murdoch.edu.au/id/eprint/31886/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400274","display_name":"Murdoch University Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I176790772","host_organization_name":"Murdoch University","host_organization_lineage":["https://openalex.org/I176790772"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:cdr.lib.unc.edu:41687v54m","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.17615/awg1-7w85","pdf_url":null,"source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antiviral Therapy, 21(7)","raw_type":"Article"},{"id":"doi:10.17615/awg1-7w85","doi":"https://doi.org/10.17615/awg1-7w85","is_oa":true,"landing_page_url":"https://doi.org/10.17615/awg1-7w85","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.3851/imp3056","doi":"https://doi.org/10.3851/imp3056","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp3056","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3056?download=true","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320989","display_name":"Murdoch University","ror":"https://ror.org/00r4sry34"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2403015085.pdf","grobid_xml":"https://content.openalex.org/works/W2403015085.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1660090100","https://openalex.org/W1964963193","https://openalex.org/W1970513021","https://openalex.org/W1973675889","https://openalex.org/W1980771473","https://openalex.org/W1989027571","https://openalex.org/W1994141249","https://openalex.org/W2001938879","https://openalex.org/W2009524460","https://openalex.org/W2019523835","https://openalex.org/W2021174540","https://openalex.org/W2024480712","https://openalex.org/W2029638039","https://openalex.org/W2039639216","https://openalex.org/W2043519223","https://openalex.org/W2047457058","https://openalex.org/W2057075704","https://openalex.org/W2081897332","https://openalex.org/W2083084243","https://openalex.org/W2087484510","https://openalex.org/W2092646281","https://openalex.org/W2099576848","https://openalex.org/W2111283804","https://openalex.org/W2112024536","https://openalex.org/W2116873531","https://openalex.org/W2125963799","https://openalex.org/W2129157300","https://openalex.org/W2132770645","https://openalex.org/W2135224352","https://openalex.org/W2135582502","https://openalex.org/W2138178197","https://openalex.org/W2140070803","https://openalex.org/W2143559032","https://openalex.org/W2152207030","https://openalex.org/W2159835094","https://openalex.org/W2163576465","https://openalex.org/W2164211111","https://openalex.org/W2168902753","https://openalex.org/W2314437205","https://openalex.org/W2419462920"],"related_works":["https://openalex.org/W2479376830","https://openalex.org/W2545708666","https://openalex.org/W2219987727","https://openalex.org/W2026381741","https://openalex.org/W7144014589","https://openalex.org/W2073675062","https://openalex.org/W2597456691","https://openalex.org/W2424853653","https://openalex.org/W2801807077","https://openalex.org/W2341470495"],"abstract_inverted_index":{"BACKGROUND:":[0],"Use":[1],"of":[2,17,50,57,155],"direct-acting":[3],"antiviral":[4],"drugs":[5],"(DAAs)":[6],"that":[7,20,81,169,204],"target":[8],"HCV":[9],"may":[10],"be":[11],"hampered":[12],"by":[13,235],"the":[14,47,55,90,153,212,232],"rapid":[15],"selection":[16],"viral":[18,77],"strains":[19,41,160,171],"harbour":[21],"drug":[22,207],"resistance-associated":[23],"variants":[24],"(RAVs).":[25],"These":[26],"RAVs":[27,53,104,162,184,203],"are":[28],"often":[29],"associated":[30],"with":[31,98],"a":[32,62],"fitness":[33],"cost":[34],"and":[35,72,94,100,123,138,167,224,242],"tend":[36],"to":[37,68,74,164,176,237],"occur":[38],"on":[39,110],"low-frequency":[40],"within":[42],"treatment-naive":[43],"subjects.":[44],"To":[45],"address":[46],"clinical":[48],"relevance":[49],"low":[51,158],"frequency":[52,159],"in":[54,79,89,149,187],"setting":[56],"DAAs,":[58],"this":[59,150,227],"study":[60,92,151],"utilized":[61],"Primer":[63,197],"ID":[64,198],"ultra-deep":[65,142,199],"sequencing":[66,146,166,200,228],"approach":[67,201,219,234],"mitigate":[69],"PCR":[70,222],"errors":[71,223],"bias":[73],"accurately":[75],"quantify":[76],"sequences":[78],"subjects":[80,115],"failed":[82],"DAA":[83],"treatment.":[84],"METHODS:":[85],"Subjects":[86],"were":[87,185,193],"enrolled":[88],"follow-up":[91,124],"P05063,":[93],"had":[95,102,116],"previous":[96],"treatment":[97],"boceprevir":[99],"all":[101],"detectable":[103],"at":[105,209],"virological":[106],"failure":[107],"(VF)":[108],"based":[109],"Sanger-based":[111],"population":[112,165,216],"sequencing.":[113,143,217],"Twelve":[114],"three":[117],"time":[118],"points":[119],"available:":[120],"baseline,":[121],"VF":[122],"(median":[125],"830.5":[126],"days).":[127],"Viral":[128],"RNA":[129],"was":[130],"amplified":[131],"using":[132,140],"unique":[133],"primer":[134],"identifiers":[135],"(Primer":[136],"IDs)":[137],"sequenced":[139],"454":[141],"RESULTS:":[144],"The":[145,196,218],"strategy":[147,229],"used":[148],"improved":[152],"detection":[154,213],"clinically":[156],"relevant":[157],"bearing":[161],"compared":[163],"showed":[168],"these":[170],"can":[172,205],"persist":[173],"for":[174,215],"up":[175],"2":[177],"years":[178],"post-treatment":[179],"failure.":[180],"Strains":[181],"carrying":[182],"multiple":[183],"common":[186],"breakthrough":[188],"viruses.":[189],"Putative":[190],"compensatory":[191],"mutations":[192],"identified.":[194],"CONCLUSIONS:":[195],"identifies":[202],"reduce":[206],"sensitivity":[208],"levels":[210],"below":[211],"threshold":[214],"also":[220],"removes":[221],"biases,":[225],"suggesting":[226],"should":[230],"become":[231],"standard":[233],"which":[236],"perform":[238],"temporal":[239],"quasispecies":[240],"studies":[241],"resistance":[243],"screening.":[244],"ClinicalTrials.gov":[245],"NCT00689390.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}